Notice of NICHD's Participation in PA-16-183 "Limited Competition: Rare Diseases Clinical Research Network (RDCRN) Project Supplements for Clinical Trials to Repurpose Drugs in Collaboration with E-Rare Awardees (Admin Supp)"

Notice Number: NOT-HD-16-016

Key Dates
Release Date: June 30, 2016  

Related Announcements
PA-16-183

Issued by
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Purpose

The purpose of this Notice is to inform potential applicants that the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) will participate, effective immediately, in PA-16-183, “Limited Competition: Rare Diseases Clinical Research Network (RDCRN) Project Supplements for Clinical Trials to Repurpose Drugs in Collaboration with E-RARE Awardees (Admin Supp)". 

The following sections have been updated to reflect the participation of NICHD in this FOA:

Part 1. Overview Information

Components of Participating Organizations
National Heart, Lung, and Blood Institute (NHLBI)
National Center for Advancing Translational Sciences (NCATS)
National Institute of Allergy and Infectious Diseases (NIAID
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Neurological Disorders and Stroke (NINDS)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Catalog of Federal Domestic Assistance (CFDA) Number(s) 
93.350, 93.855, 93.856, 93.847, 93.846, 93.837, 93.838, 93.839, 93.233, 93.840, 93.853, 93.865

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Melissa A. Parisi, MD, PhD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Telephone: 301-435-6880
Email: parisima@mail.nih.gov